← Open Payments lookup

AMY BELNAP: Open Payments

NPI 1699202044 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$335,177 in 441 payments from 14 companies in 2025. Trend: 2023 $37,969 · 2024 $180,758 · 2025 $335,177

Speaker / faculty: $249,287Travel & lodging: $39,858Honoraria: $19,339Consulting: $18,928Food & beverage: $7,766
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.145$139,121
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)143$105,392
E.R. Squibb & Sons, L.L.C.68$64,783
Axsome Therapeutics, Inc.39$24,880
ABBVIE INC.21$278
Tris Pharma Inc4$262
Teva Pharmaceuticals USA, Inc.6$169
Otsuka America Pharmaceutical, Inc.5$97
Vanda Pharmaceuticals Inc.4$93
Takeda Pharmaceuticals U.S.A., Inc.1$32

Products named: INGREZZA, CAPLYTA, COBENFY, Auvelity, VRAYLAR, Dyanavel XR, UZEDY, FANAPT.

Industry payments across ID — which companies pay providers there.